Stock Alerts on Market Activities: FINL, MRK, MRVL, VRSN, AAPL, CBS
Featuring FINL’s plan to get rid of its Man Alive brand; MRK’s recent request from the FTC; MRVL’s updated Q2 guidance; VRSN’s analyst upgrade; AAPL’s iPhone 3GS; and CBS’ new CFO.
(EMAILWIRE.COM, June 23, 2009 ) DALLAS, Texas – InvestorSoup.com announces the release of Stock Alerts covering market activities: Finish Line Inc. (Nasdaq: FINL), Merck Co. Inc. (NYSE: MRK), Marvell Technology Group Ltd. (Nasdaq: MRVL), VeriSign Inc. (Nasdaq: VRSN), Apple Inc. (Nasdaq: AAPL) and CBS Corp. (NYSE: CBS).
The stock alert features the most recent headlines, share price and technical analysis for each covered company. The full alert, as well as other articles, market research and more can be found at http://www.investorsoup.com
In the Stock Alerts, the author highlights Finish Line exiting its unprofitable Man Alive business:
“Mall-based specialty retailer Finish Line Inc. (Nasdaq: FINL) today announced a plan to exit its unprofitable Man Alive business as it focuses on its core Finish Line business. … According to the press release, Finish Line's board approved a definitive agreement with Man Alive Acquisition LLC (MA), an entity controlled by Jimmy Khezrie, the owner and operator of Jimmy Jazz stores, under which MA will assume certain assets and liabilities of Man Alive. Man Alive is a street fashion retailer offering men’s and women’s name brand fashions from the designers. As of April 17, 2009, Finish Line operated 82 Man Alive stores in 19 states. … As per agreement, MA will assume certain assets and liabilities of Man Alive (as specified in the purchase agreement), including the 75 retail stores (under both the Man Alive and Decibel names), the leasehold interests and lease liabilities of Man Alive, as well as intellectual property, including the Man Alive and Decibel trademarks and trade names.”
The Stock Alerts author also featured the FTC requesting additional information for proposed Merck and Schering-Plough merger:
“Merck Co. Inc. (Merck) (NYSE: MRK) and Schering-Plough, which are in the process of a $41.1 billion merger, recently announced they each have received a request for additional information from the U.S. Federal Trade Commission (FTC) with respect to their previously announced transaction. … The companies said they expected the request for information from the U.S. Federal Trade Commission (FTC), often referred to as a “second request,” as part of the regulatory process under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act). The companies also expressed intention to fully cooperate with federal regulators. … Three months ago, Merck agreed to buy Schering-Plough, a deal expected to create the world's second-largest drugmaker by revenue, with products including the asthma drug Singulair, Nasonex for allergies, and the heart drugs Zetia and Vytorin. … Despite the second request from the FTC, the companies still expect the deal to close in the fourth quarter. Until the merger closes, both companies will continue to operate independently.”
Investors can view all of the Stock Alerts and investment articles for free by visiting:
http://www.investorsoup.com
Join the fastest growing investor community at:
http://www.stockhideout.com
Investor Soup’s Daily Soup is one of the fastest growing small cap blogs in the investment community. Investor Soup strives each day to find the stocks that are poised to be the biggest movers before the rest of the market is aware of them.
Investor Soup.com is one of the industry’s newest and rapidly growing small-cap research providers. Investor Soup strives to provide a balanced view of many promising small cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the publicly available information available on them. For more information on Investor Soup, please visit: http://www.InvestorSoup.com
InvestorSoup.com Disclosure
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEB SITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Our newsletter and Web site have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.
Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.
InvestorSoup.com is a Web site wholly owned by BlueWave Advisors, LLC. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. BlueWave Advisors LLC, its principal and/or its affiliates will hold positions in the company profiled and may buy or sell securities at any time without notice.
Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements.
We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related sources which we believe to be reliable.
To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information).
We encourage you to invest carefully and read investment information available at the Web sites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.
The stock alert features the most recent headlines, share price and technical analysis for each covered company. The full alert, as well as other articles, market research and more can be found at http://www.investorsoup.com
In the Stock Alerts, the author highlights Finish Line exiting its unprofitable Man Alive business:
“Mall-based specialty retailer Finish Line Inc. (Nasdaq: FINL) today announced a plan to exit its unprofitable Man Alive business as it focuses on its core Finish Line business. … According to the press release, Finish Line's board approved a definitive agreement with Man Alive Acquisition LLC (MA), an entity controlled by Jimmy Khezrie, the owner and operator of Jimmy Jazz stores, under which MA will assume certain assets and liabilities of Man Alive. Man Alive is a street fashion retailer offering men’s and women’s name brand fashions from the designers. As of April 17, 2009, Finish Line operated 82 Man Alive stores in 19 states. … As per agreement, MA will assume certain assets and liabilities of Man Alive (as specified in the purchase agreement), including the 75 retail stores (under both the Man Alive and Decibel names), the leasehold interests and lease liabilities of Man Alive, as well as intellectual property, including the Man Alive and Decibel trademarks and trade names.”
The Stock Alerts author also featured the FTC requesting additional information for proposed Merck and Schering-Plough merger:
“Merck Co. Inc. (Merck) (NYSE: MRK) and Schering-Plough, which are in the process of a $41.1 billion merger, recently announced they each have received a request for additional information from the U.S. Federal Trade Commission (FTC) with respect to their previously announced transaction. … The companies said they expected the request for information from the U.S. Federal Trade Commission (FTC), often referred to as a “second request,” as part of the regulatory process under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act). The companies also expressed intention to fully cooperate with federal regulators. … Three months ago, Merck agreed to buy Schering-Plough, a deal expected to create the world's second-largest drugmaker by revenue, with products including the asthma drug Singulair, Nasonex for allergies, and the heart drugs Zetia and Vytorin. … Despite the second request from the FTC, the companies still expect the deal to close in the fourth quarter. Until the merger closes, both companies will continue to operate independently.”
Investors can view all of the Stock Alerts and investment articles for free by visiting:
http://www.investorsoup.com
Join the fastest growing investor community at:
http://www.stockhideout.com
Investor Soup’s Daily Soup is one of the fastest growing small cap blogs in the investment community. Investor Soup strives each day to find the stocks that are poised to be the biggest movers before the rest of the market is aware of them.
Investor Soup.com is one of the industry’s newest and rapidly growing small-cap research providers. Investor Soup strives to provide a balanced view of many promising small cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the publicly available information available on them. For more information on Investor Soup, please visit: http://www.InvestorSoup.com
InvestorSoup.com Disclosure
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEB SITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Our newsletter and Web site have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.
Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.
InvestorSoup.com is a Web site wholly owned by BlueWave Advisors, LLC. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. BlueWave Advisors LLC, its principal and/or its affiliates will hold positions in the company profiled and may buy or sell securities at any time without notice.
Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company’s most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements.
We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company’s plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company’s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related sources which we believe to be reliable.
To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information).
We encourage you to invest carefully and read investment information available at the Web sites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.
|
How to buy Penny Stocks
Learn the Skills, Make the Trades, Earn a Fortune! 100% Free to try. Chartpoppers.com Stop Being Fooled By "Penny Stock Picks" Subscribe To The #1 Rated MicroCap Stock Newsletter. MicroCapster.com Analyst Penny Stock Picks Visit StockSource.us for explosive stock picks, free stock research and trading tools www.StockSource.us Your text Ads here! Ads are only $575 per month. Ads are placed same day. Contac Us Emailwire.com/contact.php |